REGISTER
MedJ at ESMO 2025 with Dr. Stephen Johnston
MedJ at ESMO 2025 with Dr. Stephen Johnston is linked here to important changes in clinical thinking. The article traces the core results involving ESMO, MD, UK and explains their implications for routine care and future research.

Stephen Johnston, MD, The Royal Marsden Hospital, UK

Final OS Milestone Results of the monarchE Study Revealed – CDK4/6 Inhibitors Usher in a New Era of Clinical Cure for High-Risk HR+/HER2- Early Breast Cancer Patients! Insights on Personalized Adjuvant Treatment Strategies and Future Exploratory Directions.

0
0
Loading